drugset / Trial / NCT03776721
Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Breast cancer-related lymphedema is one of the most common and feared consequences of breast cancer treatment. Currently, lymphedema is primarily addressed conservatively with compression garments. Regenerative medicine may provide a new treatment option for lymphedema. This Phase 3 trial will examine the efficacy, effectiveness and safety of freshly isolated adipose-derived stromal cells administered in conjunction with a fat grafting procedure to the affected axillary region.
Timeline
- Start
- 2018-12-18
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | adipose-derived regenerative cells | Cell therapy | 4 ml | Other |